6625-01-345-1666
Distortion Indicator
6625013451666 013451666 8903B-001-010-051-908 HP8903B001-010-051-908
An instrument specifically designed to measure the amplitude and frequency of the constituents of a complex electrical wave form. May include transducer mechanism for converting sound pressure into electrical energy. View more Spectrum Analyzer
![]()
January 2023
7

Marketplace 6625-01-345-1666
Request a Quotation from participating marketplace vendors
Related Documents 6625-01-345-1666 1+ Documents (More...)
6625-01-345-1666 1+ Documents ( More... ) https//www.nsnlookup.com /fsg-66/fsc-6625/us 6625-01-345-1666
RQST Updated Every Day 6625-01-345-1666 RQST NE Related Documents 6625-01-345-1666 1+ Documents
Restrictions 6625-01-345-1666
6625-01-345-1666 is a Distortion Indicator This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.
Import and Export 6625-01-345-1666
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6625-01-345-1666
- Australia (ZA01)
- Effective Date:
- 4 Jun 1992
- France (ZF01)
- Effective Date:
- 1 Apr 1991
Approved Sources 6625-01-345-1666
- Part Number
- Manufacturer
- Status
- 8903B-001-010-051-908
- Manufacturer
- 1MY97 - Agilent Technologies, Inc. (Active)
- Primary Buy
- Primary Buy
- HP8903B001-010-051-908
- 28480 - Hewlett-Packard Company (Active)
- Canceled/Obsolete
- Canceled/Obsolete
Similar Supply Items to 6625-01-345-1666


















Freight Information 6625-01-345-1666
6625-01-345-1666 has freight characteristics managed by France.. 6625-01-345-1666 has a variance between NMFC and UFC when transported by rail and the description should be consulted.